Robert E. Badal
About
Robert E. Badal is a scholar working on Molecular Medicine, Pharmacology and Epidemiology.
According to data from OpenAlex, Robert E. Badal has authored 73 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Molecular Medicine, 31 papers in Pharmacology and 28 papers in Epidemiology. Recurrent topics in Robert E. Badal's work include Antibiotic Resistance in Bacteria (57 papers), Antibiotics Pharmacokinetics and Efficacy (31 papers) and Antibiotic Use and Resistance (27 papers). Robert E. Badal is often cited by papers focused on Antibiotic Resistance in Bacteria (57 papers), Antibiotics Pharmacokinetics and Efficacy (31 papers) and Antibiotic Use and Resistance (27 papers). Robert E. Badal collaborates with scholars based in United States, Taiwan and Canada. Robert E. Badal's co-authors include Daryl J. Hoban, Stephen Hawser, Samuel K. Bouchillon, Meredith Hackel, S. Bouchillon, Sibylle Lob, Po‐Ren Hsueh, Douglas J. Biedenbach, Daniel F. Sahm and Krystyna M. Kazmierczak and has published in prestigious journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and Emerging infectious diseases.
In The Last Decade
Robert E. Badal
70 papers receiving 2.7k citations
Peers
Robert E. Badal
Samuel K. Bouchillon United States
Latania K. Logan United States
Giannoula S. Tansarli United States
Carmen Peña Spain
Maria Souli Greece
Samuel L Aitken United States
José María Casellas Argentina
Dror Marchaim Israel
Ilias Karaiskos Greece
Brian A. Potoski United States
Citations per year, relative to Robert E. Badal Robert E. Badal (= 1×)
peers
Samuel K. Bouchillon
Countries citing papers authored by Robert E. Badal
Since
Specialization
Citations
This map shows the geographic impact of Robert E. Badal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert E. Badal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert E. Badal more than expected).
Fields of papers citing papers by Robert E. Badal
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Robert E. Badal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert E. Badal. The network helps show where Robert E. Badal may publish in the future.
Co-authorship network of co-authors of Robert E. Badal
This figure shows the co-authorship network connecting the top 25 collaborators of Robert E. Badal. A scholar is included among the top collaborators of Robert E. Badal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert E. Badal. Robert E. Badal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Zhang, Hui, Haishen Kong, Yunsong Yu, et al.. (2018). Carbapenem susceptibilities of Gram-negative pathogens in intra-abdominal and urinary tract infections: updated report of SMART 2015 in China. BMC Infectious Diseases. 18(1). 493–493.
2.
Lob, Sibylle, Robert E. Badal, Meredith Hackel, & Daniel F. Sahm. (2016). Epidemiology and Antimicrobial Susceptibility of Gram-Negative Pathogens Causing Intra-abdominal Infections in Pediatric Patients in Europe—SMART 2011–2014. Journal of the Pediatric Infectious Diseases Society. 6(1). piv109–piv109.
3.
Biedenbach, Douglas J., Phan Trong Giao, Phạm Hùng Vân, et al.. (2016). Antimicrobial-resistant Pseudomonas aeruginosa and Acinetobacter baumannii From Patients With Hospital-acquired or Ventilator-associated Pneumonia in Vietnam. Clinical Therapeutics. 38(9). 2098–2105.
4.
Biedenbach, Douglas J., Robert E. Badal, Mary Motyl, et al.. (2016). In Vitro Activity of Oral Antimicrobial Agents against Pathogens Associated with Community-Acquired Upper Respiratory Tract and Urinary Tract Infections: A Five Country Surveillance Study. Infectious Diseases and Therapy. 5(2). 139–153.
5.
Köksal, İftihar, Gürdal Yılmaz, Serhat Ünal, et al.. (2016). Epidemiology and susceptibility of pathogens from SMART 2011–12 Turkey: evaluation of hospital-acquired versus community-acquired urinary tract infections and ICU- versus non-ICU-associated intra-abdominal infections. Journal of Antimicrobial Chemotherapy. 72(5). dkw574–dkw574.
6.
Hackel, Meredith, Robert E. Badal, Samuel K. Bouchillon, Douglas J. Biedenbach, & Daryl J. Hoban. (2015). Resistance Rates of Intra-Abdominal Isolates from Intensive Care Units and Non-Intensive Care Units in the United States: The Study for Monitoring Antimicrobial Resistance Trends 2010–2012. Surgical Infections. 16(3). 298–304.
7.
Hayajneh, Wail, et al.. (2015). Susceptibility trends and molecular characterization of Gram-negative bacilli associated with urinary tract and intra-abdominal infections in Jordan and Lebanon: SMART 2011–2013. International Journal of Infectious Diseases. 35. 56–61.
8.
Hoban, Daryl J., Robert E. Badal, S. Bouchillon, et al.. (2014). In vitro susceptibility and distribution of beta-lactamases in Enterobacteriaceae causing intra-abdominal infections in North America 2010–2011. Diagnostic Microbiology and Infectious Disease. 79(3). 367–372.
9.
Lob, Sibylle, Robert E. Badal, Samuel K. Bouchillon, et al.. (2013). Epidemiology and Susceptibility of Gram-Negative Appendicitis Pathogens: SMART 2008–2010. Surgical Infections. 14(2). 203–208.
10.
Badal, Robert E., Samuel K. Bouchillon, Sibylle Lob, et al.. (2013). Etiology, Extended-spectrum β-lactamase Rates and Antimicrobial Susceptibility of Gram-negative Bacilli Causing Intra-abdominal Infections in Patients in General Pediatric and Pediatric Intensive Care Units—Global Data From The Study for Monitoring Antimicrobial Resistance Trends 2008 to 2010. The Pediatric Infectious Disease Journal. 32(6). 636–640.
11.
Bouchillon, S., Robert E. Badal, Daryl J. Hoban, & Stephen Hawser. (2013). Antimicrobial Susceptibility of Inpatient Urinary Tract Isolates of Gram-Negative Bacilli in the United States: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) Program: 2009−2011. Clinical Therapeutics. 35(6). 872–877.
12.
Hoban, Daryl J., Christine Lascols, Lindsay E. Nicolle, et al.. (2012). Antimicrobial susceptibility of Enterobacteriaceae, including molecular characterization of extended-spectrum beta-lactamase–producing species, in urinary tract isolates from hospitalized patients in North America and Europe: results from the SMART study 2009–2010. Diagnostic Microbiology and Infectious Disease. 74(1). 62–67.
13.
Brink, Adrian, Robert E. Badal, Guy A. Richards, et al.. (2012). Antimicrobial Susceptibility of Gram-Negative Pathogens Isolated from Patients with Complicated Intra-Abdominal Infections in South African Hospitals (SMART Study 2004–2009): Impact of the New Carbapenem Breakpoints. Surgical Infections. 13(1). 43–49.
14.
Hoban, Daryl J., Lindsay E. Nicolle, Stephen Hawser, Samuel K. Bouchillon, & Robert E. Badal. (2011). Antimicrobial susceptibility of global inpatient urinary tract isolates of Escherichia coli: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program: 2009–2010. Diagnostic Microbiology and Infectious Disease. 70(4). 507–511.
15.
Lascols, Christine, Meredith Hackel, Steve H. Marshall, et al.. (2011). Increasing prevalence and dissemination of NDM-1 metallo- -lactamase in India: data from the SMART study (2009). Journal of Antimicrobial Chemotherapy. 66(9). 1992–1997.
16.
Hawser, Stephen, D. J. Hoban, S. Bouchillon, et al.. (2010). Antimicrobial susceptibility of intra-abdominal Gram-negative bacilli from Europe: SMART Europe 2008. European Journal of Clinical Microbiology & Infectious Diseases. 30(2). 173–179.
17.
Hsueh, Po‐Ren, Robert E. Badal, Stephen Hawser, et al.. (2010). Epidemiology and antimicrobial susceptibility profiles of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia–Pacific region: 2008 results from SMART (Study for Monitoring Antimicrobial Resistance Trends). International Journal of Antimicrobial Agents. 36(5). 408–414.
18.
Hawser, Stephen, Samuel K. Bouchillon, Daryl J. Hoban, & Robert E. Badal. (2010). Epidemiologic Trends, Occurrence of Extended-Spectrum β-Lactamase Production, and Performance of Ertapenem and Comparators in Patients with Intra-Abdominal Infections: Analysis of Global Trend Data from 2002–2007 from the SMART Study. Surgical Infections. 11(4). 371–378.
19.
Hawser, Stephen, Samuel K. Bouchillon, Daryl J. Hoban, & Robert E. Badal. (2009). In vitro susceptibilities of aerobic and facultative anaerobic Gram-negative bacilli from patients with intra-abdominal infections worldwide from 2005–2007: results from the SMART study. International Journal of Antimicrobial Agents. 34(6). 585–588.
20.
Barry, A L, et al.. (1976). Short-Term Storage of Six Penicillins and Cephalothin in Microdilution Trays for Antimicrobial Susceptibility Tests. Antimicrobial Agents and Chemotherapy. 10(1). 83–88.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Samuel K. Bouchillon Breakdown of academic impact, for papers by Latania K. Logan Breakdown of academic impact, for papers by Giannoula S. Tansarli Breakdown of academic impact, for papers by Carmen Peña Breakdown of academic impact, for papers by Maria Souli Breakdown of academic impact, for papers by Samuel L Aitken Breakdown of academic impact, for papers by José María Casellas Breakdown of academic impact, for papers by Dror Marchaim Breakdown of academic impact, for papers by Ilias Karaiskos Breakdown of academic impact, for papers by Brian A. Potoski